Eastwood Bio-Medical Canada Inc.

EBM.VTSXVConsumer Defensive● Active

$0.95

+$0.09(+10.47%)

Market Cap$65441671

P/E Ratio—

52W High$1.1

52W Low$0.295

Avg Volume4K

Open$0.86

Beta0.14

Earnings Financials Revenue

Eastwood Bio-Medical Canada Inc. (EBM.V) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EBM.V · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: Apr 1, 2026

EPS Actual

$0.00

Revenue

$0.00B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

Apr 1, 2026

After Market Close

EBM.V reports quarterly as a TSXV-listed Food Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	Jun 29, 2026	—	—	—	—	—	—
— Q2 FY2026	Apr 1, 2026	—	$0.00	—	$0.00B	—	—
— Q4 FY2025	Oct 31, 2025	—	-$0.00	—	$0.00B	—	—
— Q3 FY2025	Sep 30, 2025	—	-$0.00	—	$0.00B	—	—
— Q3 FY2025	Jul 4, 2025	—	-$0.00	—	$0.00B	—	—
— Q1 FY2025	Mar 3, 2025	—	-$0.00	—	$0.00B	—	—
— Q4 FY2024	Oct 31, 2024	—	-$0.00	—	$0.00B	—	—
— Q4 FY2024	Oct 1, 2024	—	-$0.00	—	$0.00B	—	—

Q2 FY2026

Jun 29, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 1, 2026

EPS Actual

$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2025

Oct 31, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2025

Sep 30, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2025

Jul 4, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2025

Mar 3, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2024

Oct 31, 2024

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2024

Oct 1, 2024

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for EBM.V.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	Apr 1, 2026	—	$0.83	$0.92	+10.84%
— Q4 FY2025	Oct 31, 2025	—	$0.67	$0.70	+4.48%
— Q3 FY2025	Sep 30, 2025	—	$0.44	$0.44	+0.00%
— Q3 FY2025	Jul 4, 2025	—	$0.49	$0.49	+0.00%
— Q1 FY2025	Mar 3, 2025	—	$0.59	$0.59	+0.00%
— Q4 FY2024	Oct 31, 2024	—	$1.00	$0.98	-2.00%
— Q4 FY2024	Oct 1, 2024	—	$0.84	$0.84	+0.00%
— Q3 FY2024	Jul 2, 2024	—	No price data	$0.30	—

Q2 FY2026+10.84%

Report Date

Apr 1, 2026

EPS Beat/Miss

—

Price Before

$0.83

Price After

$0.92

Q4 FY2025+4.48%

Report Date

Oct 31, 2025

EPS Beat/Miss

—

Price Before

$0.67

Price After

$0.70

Q3 FY2025+0.00%

Report Date

Sep 30, 2025

EPS Beat/Miss

—

Price Before

$0.44

Price After

$0.44

Q3 FY2025+0.00%

Report Date

Jul 4, 2025

EPS Beat/Miss

—

Price Before

$0.49

Price After

$0.49

Q1 FY2025+0.00%

Report Date

Mar 3, 2025

EPS Beat/Miss

—

Price Before

$0.59

Price After

$0.59

Q4 FY2024-2.00%

Report Date

Oct 31, 2024

EPS Beat/Miss

—

Price Before

$1.00

Price After

$0.98

Q4 FY2024+0.00%

Report Date

Oct 1, 2024

EPS Beat/Miss

—

Price Before

$0.84

Price After

$0.84

Q3 FY2024—

Report Date

Jul 2, 2024

EPS Beat/Miss

—

Price Before

—

Price After

$0.30

Beat Rate0 / 8 quarters

Largest Move+10.84% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Eastwood Bio-Medical Canada Inc. (EBM.V) most recently reported earnings on April 1, 2026 for Q2 FY2026, posting EPS of $0.00 (in line with the analyst consensus of —). The next EBM.V earnings date is expected around September 1, 2026.

Each quarter, investors track EBM.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EBM.V revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

EBM.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

EBM.V earnings · 4 questions

Eastwood Bio-Medical Canada Inc.'s next earnings report is expected around September 1, 2026. EBM.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EBM.V historically reports after market close (AMC).

EBM.V earnings datewhen is EBM.V earningsEBM.V next earnings datewhen does EBM.V report earningsEBM.V earnings calendar

▸ Source: FMP · Eastwood Bio-Medical Canada Inc. SEC filings · US GAAP · Eastwood Bio-Medical Canada Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026